Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 2
1994 1
1999 1
2000 1
2002 3
2004 2
2005 2
2006 1
2007 1
2008 3
2009 2
2010 1
2011 3
2012 6
2013 3
2014 5
2015 5
2016 7
2017 6
2018 7
2019 6
2020 4
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Results by year
Filters applied: . Clear all
Page 1
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators. Richardson PG, et al. Lancet Oncol. 2019 Jun;20(6):781-794. doi: 10.1016/S1470-2045(19)30152-4. Epub 2019 May 13. Lancet Oncol. 2019. PMID: 31097405 Clinical Trial.
Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke.
Anderson CS, Arima H, Lavados P, Billot L, Hackett ML, Olavarría VV, Muñoz Venturelli P, Brunser A, Peng B, Cui L, Song L, Rogers K, Middleton S, Lim JY, Forshaw D, Lightbody CE, Woodward M, Pontes-Neto O, De Silva HA, Lin RT, Lee TH, Pandian JD, Mead GE, Robinson T, Watkins C; HeadPoST Investigators and Coordinators. Anderson CS, et al. N Engl J Med. 2017 Jun 22;376(25):2437-2447. doi: 10.1056/NEJMoa1615715. N Engl J Med. 2017. PMID: 28636854 Free article. Clinical Trial.
A cross-sectional analysis of cardiovascular disease in the hemophilia population.
Sood SL, Cheng D, Ragni M, Kessler CM, Quon D, Shapiro AD, Key NS, Manco-Johnson MJ, Cuker A, Kempton C, Wang TF, Eyster ME, Kuriakose P, von Drygalski A, Gill JC, Wheeler A, Kouides P, Escobar MA, Leissinger C, Galdzicka S, Corson M, Watson C, Konkle BA. Sood SL, et al. Blood Adv. 2018 Jun 12;2(11):1325-1333. doi: 10.1182/bloodadvances.2018018226. Blood Adv. 2018. PMID: 29895623 Free PMC article. Clinical Trial.
Beginning in October 2012, 200 patients with moderate or severe hemophilia A or B (factor VIII or IX level 5%), aged 54 to 73 years, were enrolled at 19 US hemophilia treatment centers. ...
Beginning in October 2012, 200 patients with moderate or severe hemophilia A or B (factor VIII or IX level 5%), aged 54 to 73 years, …
An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques.
Fredman G, Hellmann J, Proto JD, Kuriakose G, Colas RA, Dorweiler B, Connolly ES, Solomon R, Jones DM, Heyer EJ, Spite M, Tabas I. Fredman G, et al. Nat Commun. 2016 Sep 23;7:12859. doi: 10.1038/ncomms12859. Nat Commun. 2016. PMID: 27659679 Free PMC article.
The levels of SPMs, particularly resolvin D1 (RvD1), and the ratio of SPMs to pro-inflammatory leukotriene B(4) (LTB(4)), are significantly decreased in the vulnerable regions. ...
The levels of SPMs, particularly resolvin D1 (RvD1), and the ratio of SPMs to pro-inflammatory leukotriene B(4) (LTB(4)), are signifi …
Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural).
Shapiro AD, Ragni MV, Borhany M, Abajas YL, Tarantino MD, Holstein K, Croteau SE, Liesner R, Tarango C, Carvalho M, McGuinn C, Funding E, Kempton CL, Bidlingmaier C, Cohen A, Oldenburg J, Kearney S, Knoll C, Kuriakose P, Acharya S, Reiss UM, Kulkarni R, Witkop M, Lethagen S, Donfield S, LeBeau P, Berntorp E, Astermark J. Shapiro AD, et al. Haemophilia. 2021 Jan;27(1):49-59. doi: 10.1111/hae.14139. Epub 2020 Dec 5. Haemophilia. 2021. PMID: 33278853
INTRODUCTION: Haemophilia B (HB) is less well studied than haemophilia A (HA); despite similarities between the two inherited bleeding disorders, important differences remain that require further research. ...The majority with severe disease, 80.0% with current/history of …
INTRODUCTION: Haemophilia B (HB) is less well studied than haemophilia A (HA); despite similarities between the two inherited bleedin …
An Investigation into the High Prevalence of Hepatitis B in a Rural Area of Kerala State, India: Hypothesis on Chrysops sp. (Diptera: Tabanidae) Transmission.
Kuriakose M, Ittyachen AM. Kuriakose M, et al. Biomed Res Int. 2018 Jun 10;2018:4612472. doi: 10.1155/2018/4612472. eCollection 2018. Biomed Res Int. 2018. PMID: 29984234 Free PMC article.
OBJECTIVE: Since 2005 there have been several reports of hepatitis B outbreak in the state of Kerala in southern India. Objective of this study was to analyze such outbreaks and to explore hypothesis pertaining the transmission mode. ...The number of patients diagnosed to …
OBJECTIVE: Since 2005 there have been several reports of hepatitis B outbreak in the state of Kerala in southern India. Objective of …
Unexplained macrocytosis.
Younes M, Dagher GA, Dulanto JV, Njeim M, Kuriakose P. Younes M, et al. South Med J. 2013 Feb;106(2):121-5. doi: 10.1097/SMJ.0b013e3182824cdf. South Med J. 2013. PMID: 23380746
A total of 11.6% patients developed a primary bone marrow disorder (two B-cell lymphomas, two with myelodysplastic syndrome, one plasma cell disorder), 16.3% developed worsening cytopenias, 69.7% had stable disease, and 2.3% resolved. ...
A total of 11.6% patients developed a primary bone marrow disorder (two B-cell lymphomas, two with myelodysplastic syndrome, one plas …
Estimating the Economic Impact of Adding Panobinostat to a U.S. Formulary for Relapsed and/or Refractory Multiple Myeloma: A Budget Impact and Cost-Benefit Model.
Bloudek L, Roy A, Kish JK, Siegel DS, Jagannath S, Globe D, Orloski L, Kuriakose ET. Bloudek L, et al. J Manag Care Spec Pharm. 2016 Aug;22(8):991-1002. doi: 10.18553/jmcp.2016.22.8.991. J Manag Care Spec Pharm. 2016. PMID: 27459662
BACKGROUND: Multiple myeloma is an incurable B-cell malignancy with a natural history that involves alternating periods of remission and subsequent relapse. ...Bloukek took the lead in data collection, along with Kish, and data interpretation was performed by Siegal, Jagan …
BACKGROUND: Multiple myeloma is an incurable B-cell malignancy with a natural history that involves alternating periods of remission …
Mitral valve vegetation diagnosed with oesophageal ultrasound with bronchoscope (EUS-B).
Kattoor AJ, Rochlani YM, Kuriakose K, Meena NK. Kattoor AJ, et al. BMJ Case Rep. 2017 May 15;2017:bcr2016218849. doi: 10.1136/bcr-2016-218849. BMJ Case Rep. 2017. PMID: 28512099 Free PMC article.
Oesophageal ultrasound with bronchoscope (EUS-B) is designed to evaluate mediastinal structures. We describe a case of a 78-year-old woman who presented with altered mental status for 2 weeks. ...She was subsequently treated for infective endocarditis. We suggest that the …
Oesophageal ultrasound with bronchoscope (EUS-B) is designed to evaluate mediastinal structures. We describe a case of a 78-year-old …
68 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page